Minerva Neurosciences, Inc. (NERV) stock
NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.18+0.02 (+0.93%)
Close on Nov 18, 2026Market cap $104.09MP/E –Yield –
Minerva Neurosciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Minerva Neurosciences's market cap was $120.90M on Nov 11, 2026, against $29.23M a year earlier. Over the last 5 years it ranged from $8.49M to $285.61M, with a median of $22.31M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $120.90M | +330.0% |
| 2025 | Dec 31, 2025 | $28.11M | +81.0% |
| 2024 | Dec 31, 2024 | $15.54M | -63.9% |
| 2023 | Dec 29, 2023 | $43.01M | +406.5% |
| 2022 | Dec 30, 2022 | $8.49M | -75.2% |
| 2021 | Dec 31, 2021 | $34.22M | -65.7% |
| 2020 | Dec 31, 2020 | $99.86M | -64.0% |
| 2019 | Dec 31, 2019 | $277.47M | +6.0% |
| 2018 | Dec 31, 2018 | $261.83M | +11.8% |
| 2017 | Dec 29, 2017 | $234.14M | -42.8% |
| 2016 | Dec 30, 2016 | $408.98M | +172.6% |
| 2015 | Dec 31, 2015 | $150.06M | +35.2% |
| 2014 | Dec 31, 2014 | $111.01M | – |
See a number that looks wrong?